(Q45025078)

8 December 2017

title

Prevention of Alzheimer's disease-associated Abeta aggregation by rationally designed nonpeptidic beta-sheet ligands (English)

1 reference

8 December 2017

0 references

Luitgard Nagel-Steger

2

1 reference

8 December 2017

Sophie Feuerstein

3

0 references

author name string

Petra Rzepecki

1

1 reference

8 December 2017

Uwe Linne

4

1 reference

8 December 2017

Oliver Molt

5

1 reference

8 December 2017

Reza Zadmard

6

1 reference

8 December 2017

Katja Aschermann

7

1 reference

8 December 2017

Markus Wehner

8

1 reference

8 December 2017

Thomas Schrader

9

1 reference

8 December 2017

Detlev Riesner

10

1 reference

8 December 2017

language of work or name

English

0 references

publication date

20 August 2004

1 reference

Journal of Biological Chemistry

8 December 2017

published in

1 reference

8 December 2017

volume

279

1 reference

8 December 2017

issue

46

1 reference

8 December 2017

page(s)

47497-47505

1 reference

The prionoses and other conformational disorders

8 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M405914200

21 January 2018

Conformational disease

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M405914200

Therapeutic approaches to protein-misfolding diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M405914200

Therapeutic strategies for human amyloid diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M405914200

Perspectives of pharmacotherapy in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M405914200

Plaque busters: strategies to inhibit amyloid formation in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M405914200

Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M405914200

Peripherally administered antibodies against amyloid beta-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M405914200

Targeted pharmacological depletion of serum amyloid P component for treatment of human amyloidosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M405914200

Alzheimer's disease: genotypes, phenotypes, and treatments

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M405914200

Propagating structure of Alzheimer's beta-amyloid(10-35) is parallel beta-sheet with residues in exact register

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M405914200

De novo amyloid proteins from designed combinatorial libraries

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M405914200

Structure of amyloid A4-(1-40)-peptide of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M405914200

Inhibition of Alzheimer beta-fibrillogenesis by melatonin

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M405914200

Inhibition of beta-amyloid-induced neurotoxicity by imidazopyridoindoles derived from a synthetic combinatorial library

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M405914200

Prevention of transthyretin amyloid disease by changing protein misfolding energetics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M405914200

Nordihydroguaiaretic acid potently breaks down pre-formed Alzheimer's beta-amyloid fibrils in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M405914200

In vitro fibrillogenesis of the amyloid beta 1-42 peptide: cholesterol potentiation and aspirin inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M405914200

Beta-sheet breaker peptides inhibit fibrillogenesis in a rat brain model of amyloidosis: implications for Alzheimer's therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M405914200

Structure-function relationships for inhibitors of beta-amyloid toxicity containing the recognition sequence KLVFF.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M405914200

Inhibitors of fibril formation and cytotoxicity of beta-amyloid peptide composed of KLVFF recognition element and flexible hydrophilic disrupting element.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M405914200

Inhibition of beta-amyloid(40) fibrillogenesis and disassembly of beta-amyloid(40) fibrils by short beta-amyloid congeners containing N-methyl amino acids at alternate residues

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M405914200

Probing the role of backbone hydrogen bonding in beta-amyloid fibrils with inhibitor peptides containing ester bonds at alternate positions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M405914200

Tricine-sodium dodecyl sulfate-polyacrylamide gel electrophoresis for the separation of proteins in the range from 1 to 100 kDa

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M405914200

Two new beta-strand mimics

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M405914200

Detection of single amyloid beta-protein aggregates in the cerebrospinal fluid of Alzheimer's patients by fluorescence correlation spectroscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M405914200

Interaction between synthetic amyloid-beta-peptide (1-40) and its aggregation inhibitors studied by electrospray ionization mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M405914200

Interaction of ferrocenoyl-dipeptides with 3-aminopyrazole derivatives: beta-sheet models? A synthetic, spectroscopic, structural, and electrochemical study

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M405914200

Controlling polymerization of beta-amyloid and prion-derived peptides with synthetic small molecule ligands.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M405914200

Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M405914200

Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxins

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M405914200

Synthetic peptide homologous to beta protein from Alzheimer disease forms amyloid-like fibrils in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M405914200

21 January 2018

Identifiers

DOI

10.1074/JBC.M405914200

1 reference

8 December 2017

1 reference